Last reviewed · How we verify
NCT03350737: CARHEXA
Coronary Arteriogenetic Heparinized Exercise
NA trial testing Physical rehabilitation in Refractory Angina in 32 participants. Completed in 31 December 2019.
31 December 2019
Quick facts
| Lead sponsor | Clinical Centre of Serbia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 1 February 2013 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Serbia |
Drugs / interventions tested
- Physical rehabilitation
- Heparin (HEPARIN) — full drug profile →
- Placebo
Conditions studied
- Refractory Angina — all drugs for Refractory Angina →
- Chronic Stable Angina — all drugs for Chronic Stable Angina →
Sponsor
Clinical Centre of Serbia
Who can join
Eligibility, any sex, with Refractory Angina or Chronic Stable Angina. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the addition of heparin to a 2-week cycle of physical rehabilitation in the treatment of refractory angina. Half of the patients will undergo heparin-primed physical rehabilitation, while the other half will undergo only physical rehabilitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03350737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Physical rehabilitation
Trials testing the same drug.
- NCT05316766 — Multi-user Touch Surfaces for Promoting Social Participation and Self-efficacy in Upper-limb Stroke Rehabilitation · NA · completed
- NCT04844502 — Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis · NA · active not recruiting
- NCT07089264 — Physical Rehabilitation in Patients With Complex Congenital Heart Disease · NA · active not recruiting
Other recruiting trials for Refractory Angina
Currently open trials in the same condition.
- NCT07048808 — Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. · Phase 2 · recruiting
- NCT05711849 — Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina · Phase 2 · recruiting
- NCT05492110 — Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microva · NA · recruiting
- NCT04606459 — COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina · NA · recruiting
- NCT01566175 — Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina · NA · recruiting
Other Clinical Centre of Serbia trials
Trials by the same sponsor.
- NCT06570785 — IOPS Technology During Cannnulation of Contralateral Limb in EVAR · not yet recruiting
- NCT06253312 — Treatment of TASC C and D Aortoiliac Lesions · recruiting
- NCT05857202 — Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer · unknown
- NCT05116696 — Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer · completed
- NCT04388280 — Imaging vs. no Testing in Asymptomatic High-risk Diabetic Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03350737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinical Centre of Serbia
- Last refreshed: 13 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03350737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing